Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Genital Herpes

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

Serum Laboratory Studies, Stool Test, Breath Test

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early interventions for the prevention of preeclampsia in pregnant women at increased risk: a network meta-analysis.

The Cochrane database of systematic reviews·2026

Same author

A Systematic Review of Telomere Length and Telomerase Activity in Preeclampsia: Maternal, Placental, and Cord Blood Perspectives.

Medical sciences (Basel, Switzerland)·2026

Same author

Evaluation of Cycle Threshold (Ct) Values for Detecting High-Risk HPV in Self-Collected Vaginal Samples as a Triage Method to Colposcopy.

Diagnostics (Basel, Switzerland)·2025

Same author

Human Breast Milk miRNAs: Investigation of Association Between Breastfeeding Children and Maternal Obesity in Obesity Development in Offspring.

Genes·2025

Same author

Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.

Hormones (Athens, Greece)·2025

Same author

PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis.

JAMA network open·2025

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Can HPV testing replace the pap smear?

Theodoros Agorastos¹, Alexandros Sotiriadis, Konstantinos Chatzigeorgiou

¹4th University Clinic of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Hippokrateion Hospital of Thessaloniki, Thessaloniki, Greece. agorast@auth.gr

Annals of the New York Academy of Sciences

|September 16, 2010

Summary

High-risk human papillomavirus (HPV) testing offers superior sensitivity for detecting high-grade cervical intraepithelial neoplasia (CIN 2+) compared to the Papanicolaou smear. Adjusting HPV test cut-offs may improve specificity without compromising sensitivity.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Experiment Videos

Last Updated: Jun 8, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Area of Science:

Gynecologic oncology
Molecular diagnostics
Public health screening

Background:

The Papanicolaou (Pap) smear is the conventional method for cervical cancer screening.
High-risk human papillomavirus (HPV) testing is being evaluated as a replacement or adjunct screening method.
Balancing sensitivity and specificity is crucial for effective cervical cancer detection.

Purpose of the Study:

To evaluate the performance of high-risk HPV testing versus conventional Pap smears for detecting cervical intraepithelial neoplasia grade ≥2 (CIN 2+).
To explore strategies for optimizing HPV testing, including adjusting positivity cut-offs and triage methods.

Main Methods:

Comparative analysis of HPV testing and cytology (Pap smear) for CIN 2+ detection.
Investigation of HPV test positivity cut-offs and their impact on sensitivity and specificity.
Review of evidence supporting HPV testing's efficacy in cervical cancer screening.

Main Results:

HPV testing demonstrates higher sensitivity than cytology for detecting high-grade CIN (CIN 2+).
Increasing the HPV test cut-off may enhance specificity by reducing false positives without significantly compromising sensitivity.
Available evidence strongly supports HPV testing as a superior screening method for high-grade cervical lesions.

Conclusions:

HPV testing is a more sensitive method than Pap smears for detecting significant cervical lesions.
Optimizing HPV testing through adjusted cut-offs or improved triage strategies is key to addressing specificity concerns.
Further research focuses on enhancing HPV test sensitivity and predictive value for cervical disease.